Literature DB >> 32302965

Meeting report: "Human endogenous retroviruses: HERVs or transposable elements in autoimmune, chronic inflammatory and degenerative diseases or cancer", Lyon, France, november 5th and 6th 2019 - an MS scientist's digest.

David Kremer1, Vivien Weyers2, Joel Gruchot2, Peter Göttle2, Hans-Peter Hartung2, Hervé Perron3, Patrick Küry2.   

Abstract

The Third International Workshop on Human Endogenous Retroviruses and disease (www.hervanddisease.com), addressing HERVs or transposable elements in autoimmune, chronic inflammatory and degenerative diseases or cancer, in Lyon, France on November 5-6th 2019, once again gathered an international group of basic and clinical scientists investigating the involvement of human endogenous retroviruses (HERVs) in human diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human endogenous retroviruses; Multiple sclerosis; Neuroprotection; Temelimab; pHERV-W ENV

Year:  2020        PMID： 32302965     DOI： 10.1016/j.msard.2020.102068

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


  1 in total

Review 1.  Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease.

Authors:  Karen Giménez-Orenga; Elisa Oltra
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.